Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation

BACKGROUND: Periodontal disease is among the sixth most common inflammatory diseases worldwide with high risk to promote complications from other inflammatory diseases including diabetes, cardiovascular disease and Alzheimer’s Disease. Failure of active resolution of inflammation pathways is implica...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasturk, Hatice, Schulte, Fabian, Martins, Melissa, Sherzai, Homa, Floros, Constantinos, Cugini, MaryAnn, Chiu, Chung-Jung, Hardt, Markus, Van Dyke, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475270/
https://www.ncbi.nlm.nih.gov/pubmed/34589083
http://dx.doi.org/10.3389/fimmu.2021.704163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475270/
https://www.ncbi.nlm.nih.gov/pubmed/34589083
http://dx.doi.org/10.3389/fimmu.2021.704163

Ejemplares similares